Skip to main content

Articles

Challenges in the Management of Agitation Associated with Schizophrenia and Bipolar Disorder
Read More
Understanding Similarities and Differences in Agitation Associated with Schizophrenia and Bipolar Disorder
Read More
FDA Approvals, In the News
FDA Approves Integra Omnigraft Dermal Regeneration Matrix to Treat Diabetic Foot Ulcers
Read More
FDA Approvals
Onivyde (Irinotecan Liposome Injection) a New Treatment Option for Patients with Metastatic Pancreatic Cancer
Read More
Perspectives
Coping with Agitation Associated with Schizophrenia and Bipolar Disorder: How Can Healthcare Professionals Help Their Patients?
Read More
Why You Should Know About Project BETA: Best Practices in Evaluation and Treatment of Agitation
Read More
Helping Patients Cope with Agitation: The Role of Pharmacists and Payers
Read More
Aligning Proactive Agitation Management in Clinical Settings
Read More
Epidemiologic Assessments of Abuse-Deterrent Formulations
Read More
Abuse-Deterrent Formulations: An Early Epidemiologic Appraisal
Read More
Page 120 of 244
Results 1191 - 1200 of 2434